• Skip to main content
  • Skip to header right navigation
  • Skip to site footer
IMCS

IMCS

A leader in recombinant enzymes and automated micro-chromatography technologies

  • ABOUT
    • ABOUT IMCS
    • QUALITY POLICY
    • RESEARCH AT IMCS
    • CAREERS
  • PRODUCTS
    • IMCSzyme®
      • IMCSzyme E1F
      • IMCSzyme RT
      • IMCSzyme® CATALOG
    • IMCStips®
      • APPLICATIONS
        • AFFINITY
        • SIZE EXCLUSION
        • NUCLEIC ACIDS
        • ION EXCHANGE
        • REVERSE PHASE
        • PHOSPHOPEPTIDE
      • IMCStips® CATALOG
      • AUTOMATION PLATFORMS
        • DYNAMIC DEVICES
        • HAMILTON
        • INTEGRA
        • TECAN
        • OPENTRONS
        • ANALYTIK JENA
    • SULFATASES
      • Sulfazyme
      • Sulfazyme™ DS
      • Sulfazyme™ β-AS
    • GLYCO REAGENTS
      • GLYCOLIPIDS
      • ACTIVATED SUGARS
      • BIOSYNTHETIC ENZYMES
      • SMALL MOLECULES
    • SPHINGOSINES
    • OTHER PROTEINS
      • PURIFIED STREPTAVIDIN
      • B. pi. β-glucuronidase variant
  • SERVICES
    • BETA-GLUCURONIDASES & SULFATASES
      • β-GLUCURONIDASE VALIDATION SERVICES
      • HIGH-THROUGHPUT TOXICOLOGY WORKFLOWS
    • IMCStips®
      • SAMPLE PREPARATION AUTOMATION
      • HIGH-THROUGHPUT METHOD DEVELOPMENT
      • AUTOMATION PLATFORMS
        • DYNAMIC DEVICES
        • HAMILTON
        • INTEGRA
        • TECAN
        • OPENTRONS
        • ANALYTIK JENA
    • OTHER SERVICES
      • GLYCAN PRODUCTION (Coming Soon)
      • R&D COLLABORATIONS
      • EXTRACELLULAR VESICLES
  • RESOURCES
    • FAQ
    • IMCSZYME RESOURCES
    • IMCSTIPS RESOURCES
    • SAFETY DATA SHEETS
    • CERTIFICATE OF ANALYSIS
  • LATEST NEWS
    • LATEST NEWS
    • PODCAST
    • BLOG
    • EVENTS
    • WEBINARS
  • SHOP
  • CONTACT
  • en
    • en
    • es
    • fr
    • de
    • zh-CN
Image of blue rendered molecular structure

LATEST NEWS

3 WAYS RESEARCHERS ARE TACKLING THE SCIENCE OF DRUG ADDICTION

May 15, 2019

Over 21,000,000 Americans have a problematic addiction to drugs, from alcohol to black-market opiates and everything in between. The World Health Organization estimates that globally, over 5% of the world’s disease burden can be attributed directly to drug and/or alcohol abuse. Researchers have been studying the science behind drug addiction for the better part of a century. At any …

Read more3 WAYS RESEARCHERS ARE TACKLING THE SCIENCE OF DRUG ADDICTION

HOW BIOTECHNOLOGY IS IMPROVING THE HUMAN BODY

March 12, 2019

Thanks to new advancements in technology, biotech applications are improving the human body in more ways than one. From proteomics and stem cells to gene variations and synthetic biology, biotechnology is refining the quality of our lives with out us even knowing.  Check out the infographic below for an in-depth look at a few ways …

Read moreHOW BIOTECHNOLOGY IS IMPROVING THE HUMAN BODY
Image of a swimmer doing laps in a blue wet cap

3 RECENT ADVANCEMENTS IN ANTI-DOPING TESTING FOR ATHLETES

February 25, 2019

Anti-doping technology has never been more advanced. As performance athletics around the world grow in stature and profitability, athletes (and more notably, their trainers) are continuing to look for new ways to circumvent traditional drug testing methods. The stakes have never been higher. The most recent advancements in athlete drug testing are almost incomprehensible. Here …

Read more3 RECENT ADVANCEMENTS IN ANTI-DOPING TESTING FOR ATHLETES

THE HIDDEN COSTS OF LENGTHY DRUG INCUBATION TIMES

February 11, 2019

Drugs of abuse testing is, in some ways, an imperfect science. With new innovations developing within the industry almost annually, best-practices for drug testing have become muddled, varying sharply from lab to lab. One of the most common effects of an inefficient drug testing process, lengthy incubation times can have a significant negative impact on results, reliability, …

Read moreTHE HIDDEN COSTS OF LENGTHY DRUG INCUBATION TIMES

3 CHANGES ON THE HORIZON FOR PRECISION MEDICINE

February 8, 2019

Precision medicine is quickly moving from the research phase to clinical application. The science of using genes, proteins, and environmental information to provide personalized patient treatment isn’t a new one, but technology is finally catching up to speculation. IMCS is a biotechnology company helping to advance the science of precision medicine. Our groundbreaking IMCStips are designed …

Read more3 CHANGES ON THE HORIZON FOR PRECISION MEDICINE
Image of a spilled pill bottle with red and white pills

WHY FALSE POSITIVES ARE PROBLEMATIC FOR OPIOID TESTING

January 20, 2019

Testing for Opioid Use It’s no wonder so many businesses, governmental entities, and organizations are vested in more accurate testing for opioid use. The trouble with opioids is that they can be used both legally and illegally; for many, prescription painkillers act as a gateway to other, harder opioids like heroin. In 2015, nearly half …

Read moreWHY FALSE POSITIVES ARE PROBLEMATIC FOR OPIOID TESTING
  • Previous
  • Page 1
  • Interim pages omitted …
  • Page 4
  • Page 5
  • Page 6

Customize Your Workflow

IMCS recognizes our customers’ needs vary, which is why we provide tailored tools and services to help you reach your laboratory’s goals.

VIEW OUR CUSTOM SOLUTIONS

ABOUT IMCS

INTEGRATED MICRO-CHROMATOGRAPHY SYSTEMS, INC. (IMCS) IS A BIOTECHNOLOGY COMPANY FOCUSED ON DELIVERING TOOLS AND SERVICES THAT HELP PAVE THE WAY FOR THE FUTURE OF PRECISION MEDICINE. WE STRIVE TO ADDRESS THE GROWING NEEDS OF CLINICAL AND RESEARCH LABORATORIES THROUGH ADVANCED TECHNOLOGIES THAT INCREASE TESTING EFFICIENCY AND ACCURACY.

STAY UP TO DATE

WANT REGULAR UPDATES ON OUR INNOVATIVE PRODUCTS?
Sign up to receive exclusive emails and offers from IMCS.
!
!
!
Subscribe
Something went wrong. Please check your entries and try again.

ABOUT

ABOUT IMCS

CAREERS

QUALITY POLICY

RESEARCH AT IMCS

PRODUCTS

IMCSZYME

IMCSZYME RT

IMCSTIPS

PROTEINS, ENZYMES, RESINS

GLYCO REAGENTS

TERMS

TERMS OF USE

PRIVACY POLICY

STANDARD TERMS AND CONDITIONS

FCOI POLICY

CONNECT WITH US

IMCS, Inc. Headquarters
110 Centrum Drive
Irmo, SC 29063

  • IMCS LinkedIn Page
  • IMCS Facebook Page
  • IMCS Twitter Page

COPYRIGHT © 2026 · IMCS · ALL RIGHTS RESERVED ·

Return to top

Caleb-Schlachter-for-web

Caleb R. Schlachter, Ph.D.

Principal Scientist
Caleb R. Schlachter, Ph.D., as the Principal Scientist at IMCS, leads and provides guidance for several research and development projects that involve proteins, including enzymes for glycan hydrolysis and glycan synthesis. He has co-authored multiple patents, posters, and peer-reviewed articles on β-glucuronidases and sulfatases.
Gray Amick for web

Gray D. Amick, Ph.D.

Director of Operations
Gray D. Amick, Ph.D., is the Director of Operations at IMCS with over 26 years of experience in forensic DNA analysis and toxicology. Prior to joining IMCS, he led forensic DNA testing for the Richland County Sheriff’s Department as technical leader and lab director. He has been court-qualified as an expert over 100 times and has authored and co-authored multiple posters and peer-reviewed articles.
Amanda M Headshot

Amanda C. McGee

Research Scientist
Amanda C. McGee is a Research Scientist at IMCS involved with enzyme characterizations, new analytical method developments, and advanced technical support. She joined IMCS with several years of experience in analytical testing for active pharmaceutical ingredients as per cGMP, USP and ICH guidelines. She has co-authored peer reviewed articles in the Journal of Analytical Toxicology and presented research at national and international conferences.
Andrew_Headshot

L. Andrew Lee, Ph.D.

Co-Founder and Chief Scientific Officer
L. Andrew Lee, Ph.D. co-founded IMCS and leads research and development efforts in enzyme engineering and automated micro-chromatography workflows. He directs new market efforts in glycan synthesis, supported by three NIH Fast-Track awards.

Get started with 2N1 below

"*" indicates required fields

Name*
Would you be interested in joining the 2N1 beta program?*
Which product are you interested in? (select all that apply)*
What are your current purification workflows? (select all that apply)*
Please select your automation platform(s) (select all that apply)*
How soon are you planning on evaluating 2N1?*
Consent*

DOWNLOAD OUR POSTERS

"*" indicates required fields

This field is for validation purposes and should be left unchanged.
Please select the posters you would like to download*
Name*
Please provide a valid email so we can send you the download link.
Location*
Automated Liquid Handling System
Contact preferences*
Consent*

Podcast Form

"*" indicates required fields

Name*
How would you like to connect?*
Please let us know what's on your mind. Have a question for us? Ask away.

Ready for a change? Get your FREE sample of IMCSzyme® RT today.

"*" indicates required fields

This field is for validation purposes and should be left unchanged.
Name*
Consent*